These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36782062)

  • 1. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells.
    Hong Y; Yang Q; Song H; Ming GL
    Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New considerations for hiPSC-based models of neuropsychiatric disorders.
    Hoffman GE; Schrode N; Flaherty E; Brennand KJ
    Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
    Wang M; Zhang L; Gage FH
    Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?
    Prytkova I; Goate A; Hart RP; Slesinger PA
    Alcohol Clin Exp Res; 2018 Sep; 42(9):1572-1590. PubMed ID: 29897633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.
    Flaherty EK; Brennand KJ
    Brain Res; 2017 Jan; 1655():283-293. PubMed ID: 26581337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
    Dalvi S; Galloway CA; Singh R
    Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Disease with Human Inducible Pluripotent Stem Cells.
    Grandy R; Tomaz RA; Vallier L
    Annu Rev Pathol; 2019 Jan; 14():449-468. PubMed ID: 30355153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.
    Pratumkaew P; Issaragrisil S; Luanpitpong S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells.
    Tobe BT; Snyder EY; Nye JS
    Curr Opin Pharmacol; 2011 Oct; 11(5):521-7. PubMed ID: 21723195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational potential of hiPSCs in predictive modeling of heart development and disease.
    Mansfield C; Zhao MT; Basu M
    Birth Defects Res; 2022 Oct; 114(16):926-947. PubMed ID: 35261209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited cardiac diseases, pluripotent stem cells, and genome editing combined-the past, present, and future.
    van den Brink L; Grandela C; Mummery CL; Davis RP
    Stem Cells; 2020 Feb; 38(2):174-186. PubMed ID: 31664757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells.
    Ho SM; Hartley BJ; Tcw J; Beaumont M; Stafford K; Slesinger PA; Brennand KJ
    Methods; 2016 May; 101():113-24. PubMed ID: 26626326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells.
    Muhtaseb AW; Duan J
    Schizophr Res; 2022 Apr; ():. PubMed ID: 35459617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.
    Goedel A; My I; Sinnecker D; Moretti A
    Curr Cardiol Rep; 2017 Mar; 19(3):23. PubMed ID: 28220464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia.
    Balan S; Toyoshima M; Yoshikawa T
    Neurobiol Dis; 2019 Nov; 131():104162. PubMed ID: 29729395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.